Shuang Guo Selected Research

Competitive Endogenous RNA

10/2021	SH3PXD2A-AS1/miR-330-5p/UBA2 ceRNA network mediates the progression of colorectal cancer through regulating the activity of the Wnt/β-catenin signaling pathway.
1/2021	LnCeCell: a comprehensive database of predicted lncRNA-associated ceRNA networks at single-cell resolution.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shuang Guo Research Topics

Disease

32	Neoplasms (Cancer) 01/2024 - 10/2013
9	Inflammation (Inflammations) 01/2023 - 01/2012
6	Ischemic Stroke 10/2023 - 12/2018
5	Type 2 Diabetes Mellitus (MODY) 03/2024 - 01/2020
5	Fibrosis (Cirrhosis) 01/2024 - 01/2012
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 01/2017
5	Diabetic Cardiomyopathies 08/2023 - 01/2012
5	COVID-19 02/2022 - 01/2021
5	Insulin Resistance 01/2021 - 10/2013
4	Infections 11/2023 - 01/2019
4	Myocardial Infarction 09/2023 - 09/2022
4	Obesity 09/2023 - 10/2013
4	Colorectal Neoplasms (Colorectal Cancer) 04/2023 - 10/2021
4	Spinal Cord Injuries (Spinal Cord Injury) 01/2023 - 01/2018
4	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2014
4	Body Weight (Weight, Body) 02/2020 - 01/2014
3	Ovarian Neoplasms (Ovarian Cancer) 01/2024 - 11/2015
3	Atherosclerosis 03/2023 - 09/2022
3	Infarction (Infarctions) 01/2023 - 01/2019
3	Neoplasm Metastasis (Metastasis) 01/2021 - 10/2014
3	Weight Gain 12/2020 - 01/2016
3	Fever (Fevers) 08/2020 - 01/2017
3	Fetal Growth Retardation (Intrauterine Growth Retardation) 01/2020 - 01/2019
3	Catalepsy 04/2019 - 01/2016
2	Heart Failure 01/2024 - 09/2023
2	Hepatocellular Carcinoma (Hepatoma) 12/2023 - 01/2022
2	Wounds and Injuries (Trauma) 11/2023 - 12/2022
2	Hypertension (High Blood Pressure) 09/2023 - 01/2023
2	Hyperlipidemias (Hyperlipidemia) 09/2023 - 12/2020
2	Cardiotoxicity 08/2023 - 01/2021
2	Diabetes Mellitus 03/2023 - 09/2021
2	Melanoma (Melanoma, Malignant) 01/2023 - 01/2023
2	Colonic Neoplasms (Colon Cancer) 01/2023 - 01/2013
2	Virus Diseases (Viral Diseases) 12/2022 - 01/2021
2	Mastitis 12/2022 - 03/2020
2	Brain Ischemia (Cerebral Ischemia) 01/2022 - 12/2018
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 09/2021 - 08/2017
2	Hyperglycemia 01/2021 - 12/2020
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 09/2018 - 08/2017
1	Vascular System Injuries 03/2024
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2024

Drug/Important Bio-Agent (IBA)

11	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2014
9	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2015
7	CytokinesIBA 01/2024 - 01/2019
7	Messenger RNA (mRNA)IBA 12/2023 - 01/2015
6	Glucose (Dextrose)FDA LinkGeneric 03/2024 - 10/2013
6	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2019
5	Blood Glucose (Blood Sugar)IBA 05/2023 - 01/2014
5	Long Noncoding RNAIBA 12/2021 - 01/2018
5	ResveratrolIBA 09/2021 - 01/2018
4	Vitamin D FDA LinkGeneric 04/2023 - 06/2021
4	MicroRNAs (MicroRNA)IBA 11/2021 - 01/2018
3	Therapeutic UsesIBA 01/2024 - 06/2019
3	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2023 - 01/2019
3	Streptozocin (Streptozotocin)FDA Link 08/2023 - 09/2021
3	Interleukin-6 (Interleukin 6)IBA 03/2023 - 01/2021
3	Interleukin-10 (Interleukin 10)IBA 03/2023 - 01/2021
3	Arginine (L-Arginine)FDA Link 01/2020 - 01/2019
3	N-carbamylglutamateIBA 01/2020 - 01/2019
3	SaponinsIBA 09/2019 - 01/2017
3	Phencyclidine (Angel Dust)IBA 04/2019 - 01/2016
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019 - 01/2017
3	CurcuminIBA 11/2018 - 01/2012
2	Sirtuin 1IBA 01/2024 - 01/2017
2	CalciumIBA 01/2024 - 12/2018
2	puerarinIBA 01/2024 - 08/2017
2	A-Form DNA (A-DNA)IBA 11/2023 - 01/2019
2	Circular RNAIBA 10/2023 - 01/2021
2	Oxygen (Dioxygen)IBA 10/2023 - 09/2021
2	SeleniumIBA 09/2023 - 12/2022
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2023 - 01/2023
2	InterleukinsIBA 03/2023 - 01/2019
2	EnzymesIBA 03/2023 - 01/2012
2	Interleukin-17 (Interleukin 17)IBA 03/2023 - 01/2023
2	omega-Chloroacetophenone (Mace)IBA 03/2023 - 01/2023
2	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2022
2	LipopolysaccharidesIBA 12/2022 - 01/2018
2	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2020
2	VaccinesIBA 01/2022 - 01/2019
2	ChromatinIBA 01/2022 - 10/2014
2	Competitive Endogenous RNAIBA 10/2021 - 01/2021
2	Caspase 3 (Caspase-3)IBA 09/2021 - 01/2012
2	AntioxidantsIBA 01/2021 - 10/2019
2	Phosphotransferases (Kinase)IBA 01/2021 - 10/2013
2	Interleukin-33IBA 04/2020 - 01/2019
2	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 11/2015
2	Histamine H1 Receptors (Histamine H1 Receptor)IBA 01/2017 - 01/2016
2	Promyelocytic Leukemia ProteinIBA 08/2014 - 10/2013
1	Thrombospondin 1IBA 03/2024
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 03/2024
1	alizarinIBA 03/2024
1	Protein Isoforms (Isoforms)IBA 01/2024
1	TESIBA 12/2023
1	Peptidoglycan (Murein)IBA 11/2023
1	Nucleotide AptamersIBA 11/2023

Therapy/Procedure

14	Therapeutics 01/2024 - 01/2014
7	Immunotherapy 01/2024 - 01/2021
6	Drug Therapy (Chemotherapy) 09/2023 - 11/2015
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 10/2023 - 01/2017
3	Low-Level Light Therapy (LLLT) 01/2021 - 01/2020